GlassScriptPhysician profile
Chad Eric Walls
NPI 1508177544
$3,144.41
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,463 · 2020: $160 · 2021: $121 · 2022: $599 · 2023: $403 · 2024: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $800.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,545.93 | 2019-2023 | T2 Alpha |
| Arthrex, INC. | $546.34 | 2022-2024 | Distal Extremities Implants Trauma, Extremities & Trauma Implants Long Bone Trauma Femoral Fracture, Distal Extremities Implants Trauma Ankle Fracture |
| Zimmer Biomet Holdings, INC. | $282.14 | 2022-2023 | Affixus, Ncb, A.L.P.S. |
| Innovation Technologies INC | $169.10 | 2021-2023 | Irrisept |
| Depuy Synthes Sales INC. | $163.02 | 2020-2024 | Va-Lcp |
| Novus Surgical Consultants | $126.72 | 2024 | |
| Endo Pharmaceuticals INC. | $84.99 | 2019 | |
| Si-Bone, INC. | $67.56 | 2021-2023 | |
| Heraeus Medical, LLC. | $57.85 | 2020 | |
| Kerecis Limited | $39.21 | 2022 | |
| Cerapedics INC. | $38.22 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Mid-Atlantic Surgical Systems, LLC | $23.33 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Walls listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.